CUSIP: 74374N102
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,981,743
-
Share change
-
+926,647
-
Total reported value
-
$99,923,808
-
Put/Call ratio
-
24%
-
Price per share
-
$4.00
-
Number of holders
-
109
-
Value change
-
+$2,841,504
-
Number of buys
-
54
-
Number of sells
-
44
Quarterly Holders Quick Answers
What is CUSIP 74374N102?
CUSIP 74374N102 identifies PRVB - PROVENTION BIO INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP 74374N102:
Institutional Holders of PROVENTION BIO INC - COM (PRVB) as of Q2 2022
As of 30 Jun 2022,
PROVENTION BIO INC - COM (PRVB) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,981,743 shares.
The largest 10 holders included
Sessa Capital IM, L.P., BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, VR Adviser, LLC, Verition Fund Management LLC, GEODE CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., DG Capital Management, LLC, and BIOIMPACT CAPITAL LLC.
This page lists
109
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.